POEMS syndrome with necrotizing vasculitis: A novel feature of vascular abnormalities
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare multisystem disorder. Although its pathogenesis remains elusive, there is evidence that vasculopathy may have an important role.1-3 We report an autopsied case of POEMS syndrome in which necrotizing vasculitis was identified as a salient pathologic feature.
Case report.
A 63-year-old man was admitted to the hospital because of difficulty in walking and a tingling sensation in his legs. On physical examination, edema of the bilateral legs was prominent. Neurologic examination revealed muscle weakness and atrophy of the legs, more marked in the proximal muscles, and deep-tendon reflexes were diminished.
Blood cell counts showed mild leukocytosis and thrombocytosis. Tests for autoantibodies such as rheumatoid factor, cryoglobulin, anti-ribonucleoprotein (RNP) antibody, anti-double stranded DNA antibody, anti-SS-A/Ro antibody, and antineutrophil cytoplasmic autoantibody (ANCA) were negative. Serum level of vascular endothelial growth factor (VEGF) was elevated (>2000 pg/mL). Hyperprolactinemia (339.7 ng/mL) was noted. The level of testosterone was decreased (0.4 ng/dL). Estradiol level was elevated (79 ng/mL). There was impaired glucose tolerance. M-protein (IgGλ) was detected in the serum. Motor and sensory conduction velocity of the peripheral nerves was reduced. …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Raised VEGFHigh sensitivity and specificity in the diagnosis of POEMS syndromeMorgane Pihan, Stephen Keddie, Shirley D'Sa et al.Neurology: Neuroimmunology & Neuroinflammation, August 15, 2018 -
Articles
Vascular endothelial growth factor in CSFA biological marker for carcinomatous meningitisG. Stockhammer, W. Poewe, S. Burgstaller et al.Neurology, April 25, 2000 -
Articles
Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndromeKazuaki Kanai, Setsu Sawai, Kazuyuki Sogawa et al.Neurology, July 25, 2012 -
Brief Communications
Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndromeK. Michizono, F. Umehara, T. Hashiguchi et al.Neurology, March 27, 2001